Milton C. Ault III - 17 Dec 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
17 Dec 2021
Net transactions value
+$84,969
Form type
4
Filing time
20 Dec 2021, 18:44:36 UTC
Previous filing
16 Dec 2021
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $32,304 +13,000 +0.19% $2.48* 6,920,388 17 Dec 2021 By Digital Power Lending, LLC F1, F2
transaction ALZN Common Stock Purchase $52,665 +25,000 +0.36% $2.11* 6,920,388 20 Dec 2021 By Digital Power Lending, LLC F2, F3
holding ALZN Common Stock 6,920,388 17 Dec 2021 Direct
holding ALZN Common Stock 15,000,000 17 Dec 2021 By Ault Life Sciences, Inc. F4
holding ALZN Common Stock 10,000,000 17 Dec 2021 By Ault Life Sciences Fund, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.4849. The range of purchase prices on the transaction date was $2.44 to $2.56 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2 Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F3 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.1066. The range of purchase prices on the transaction date was $2.07 to $2.25 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F5 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.